Michele Peake Andrasik
Overview
Explore the profile of Michele Peake Andrasik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thiam-Diouf A, Metch B, Sharpe C, Mulugeta R, Andrasik M
Vaccine
. 2018 Feb;
36(9):1235-1242.
PMID: 29395528
Background: The primary objectives of HIV Vaccine Trials Network (HVTN) phase 1 preventive HIV vaccine clinical trials are to assess safety and immune response to study products. Participant alcohol and...
2.
Andrasik M, Clad R, Bove J, Tsegaselassie S, Morris M
AIDS Behav
. 2015 Feb;
19(10):1782-91.
PMID: 25711296
We evaluate an innovative grassroots community-based campaign in Seattle, WA focused on educating African American and African-born communities about concurrent partnerships and HIV transmission. Respondents completed a short self-administered questionnaire...
3.
Andrasik M, Chandler C, Powell B, Humes D, Wakefield S, Kripke K, et al.
Am J Public Health
. 2014 Feb;
104(4):708-14.
PMID: 24524520
Objectives: We obtained contextual information regarding documented barriers to HIV clinical trial participation among Black men who have sex with men (MSM), and explored current preventive HIV clinical trial attitudes,...
4.
Andrasik M, Karuna S, Nebergall M, Koblin B, Kublin J
Vaccine
. 2013 Jul;
31(40):4398-405.
PMID: 23859840
In HIV vaccine trials, the collection and analysis of participant behavior data associated with risk of acquiring HIV-infection is important for a number of reasons. Although the rationale for behavioral...
5.
Andrasik M, Otto J, Nguyen H, Burris L, Gilmore A, George W, et al.
Arch Sex Behav
. 2013 Jun;
42(8):1487-99.
PMID: 23740468
Scenarios simulating real-world risk situations have proven effective for substance use intervention methods and could potentially prove useful as an HIV-prevention method. This study explored qualitatively the development and use...
6.
Andrasik M, Yoon R, Mooney J, Broder G, Bolton M, Votto T, et al.
Prev Sci
. 2013 Mar;
15(3):268-76.
PMID: 23446435
Observed seroincidence and prevalence rates in male-to-female (MTF) transgender individuals highlight the need for effective targeted HIV prevention strategies for this community. In order to develop an effective vaccine that...
7.
Andrasik M, Chapman C, Clad R, Murray K, Foster J, Morris M, et al.
AIDS Educ Prev
. 2012 Dec;
24(6):527-48.
PMID: 23206202
In the United States, Blacks are disproportionately impacted by HIV/AIDS. Sexual networks and concurrent relationships have emerged as important contributors to the heterosexual transmission of HIV. To date, Africa is...
8.
Antoni M, Pereira D, Marion I, Ennis N, Andrasik M, Rose R, et al.
J Psychosom Res
. 2008 Sep;
65(4):389-401.
PMID: 18805249
Objective: Risk for developing cervical neoplastic disease is greatly increased in women infected with oncogenic sexually transmitted human papillomaviruses (HPVs) and who have lowered cellular immunity due to coinfection with...
9.
Andrasik M, Rose R, Pereira D, Antoni M
J Health Care Poor Underserved
. 2008 Aug;
19(3):912-25.
PMID: 18677078
This study elucidates the perspective of low-income HIV-positive African American women who have not received cervical cancer screening for five or more years, on the barriers they face in accessing...